Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04776928 · ClinicalTrials.gov registry record · NA
Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing
A NA study of Opioid Prescribing, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
- 1
- Study location
NCT04776928: Completed NA study of Opioid Prescribing, sponsored by University of Michigan.
NCT04776928 is a NA study of Opioid Prescribing that has completed, run by University of Michigan. The registered enrollment target is 217 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04776928, a NA study of Opioid Prescribing, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives. The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing. The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants). The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.
Primary Outcome
Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.
Conditions Studied
Interventions
- BEHAVIORAL Push reports
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2022-08-17 |
| Phase | NA |
What the finished NCT04776928 record still lists
NCT04776928 is an interventional study that assigns participants to a tested intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Opioid Prescribing appearing as the primary indexed condition, and to 1 intervention - of which Push reports is the first listed.
NCT04776928 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04776928 about?
NCT04776928 is a clinical study titled "Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing". The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guideline...
What is the current status of trial NCT04776928?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2022-03-17. Estimated completion is 2022-08-17.
What conditions does trial NCT04776928 study?
This clinical trial studies the following conditions: Opioid Prescribing.
What interventions are being tested in trial NCT04776928?
The interventions under investigation include: Push reports (BEHAVIORAL).
Who is sponsoring clinical trial NCT04776928?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04776928 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Prescribing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04776928's enrollment target sits among peer trials
217 485th of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI